<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005362A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005362</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13976914</doc-number><date>20111229</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>PL</country><doc-number>PL393529</doc-number><date>20101231</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>14</main-group><subgroup>21</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>14</main-group><subgroup>21</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>530371</main-classification><further-classification>530350</further-classification><further-classification>536 234</further-classification><further-classification>4353201</further-classification><further-classification>530370</further-classification></classification-national><invention-title id="d0e61">RECOMBINANT CYTOTOXIN AS WELL AS A METHOD OF PRODUCING IT</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Bujko</last-name><first-name>Anna</first-name><address><city>Kalisz</city><country>PL</country></address></addressbook><residence><country>PL</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Lukasiak</last-name><first-name>Magdalena</first-name><address><city>Parzeczew</city><country>PL</country></address></addressbook><residence><country>PL</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Dastych</last-name><first-name>Jaroslaw</first-name><address><city>Lodz</city><country>PL</country></address></addressbook><residence><country>PL</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Skupinska</last-name><first-name>Miroslawa</first-name><address><city>Poznan</city><country>PL</country></address></addressbook><residence><country>PL</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Rodakowska</last-name><first-name>Ewelina</first-name><address><city>Kostrzyn</city><country>PL</country></address></addressbook><residence><country>PL</country></residence></us-applicant><us-applicant sequence="05" app-type="applicant" designation="us-only"><addressbook><last-name>Rychlewski</last-name><first-name>Leszek</first-name><address><city>Poznan</city><country>PL</country></address></addressbook><residence><country>PL</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Bujko</last-name><first-name>Anna</first-name><address><city>Kalisz</city><country>PL</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Lukasiak</last-name><first-name>Magdalena</first-name><address><city>Parzeczew</city><country>PL</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Dastych</last-name><first-name>Jaroslaw</first-name><address><city>Lodz</city><country>PL</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Skupinska</last-name><first-name>Miroslawa</first-name><address><city>Poznan</city><country>PL</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Rodakowska</last-name><first-name>Ewelina</first-name><address><city>Kostrzyn</city><country>PL</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Rychlewski</last-name><first-name>Leszek</first-name><address><city>Poznan</city><country>PL</country></address></addressbook></inventor></inventors></us-parties><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/PL2011/050058</doc-number><kind>00</kind><date>20111229</date></document-id><us-371c124-date><date>20130916</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The subject of the present invention is a method of modifying proteinaceous toxins through the addition of an NLS motif. The resulting cytotoxin facilitates the selective elimination of proliferating cells, particularly tumour cells.</p></abstract></us-patent-application>